The Pfizer/BioNTech bivalent COVID-19 vaccine (both Original and Omicron BA.4/BA.5) is already FDA-authorized under an EUA for use in individuals 12 years old and above as a single booster dose ...
30, children were 26.7% of reported weekly Covid-19 cases. The FDA has set a date of Oct. 26 for outside advisers to meet and discuss the Pfizer application, making it possible for kids to begin ...
and the U.S. Food and Drug Administration (FDA) about a possible “safety signal” for the Pfizer-BioNTech Covid-19 bivalent booster vaccine. Not surprisingly the chatter has been a bit like the ...
The COVID vaccine may ... given with a high-dose flu shot, primarily in seniors over 85, according to new FDA analyses. The ...
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.
The FDA announcement did mention studies that compared the use of bivalent boosters and ... she receives a Moderna Omicron Covid-19 booster ... [+] vaccine on February 17 in a clinical study ...
Aiming to provide additional protection for Americans against the coronavirus over the upcoming flu season, the FDA ... The new shots have been updated to better protect against a more recent omicron ...
What’s behind the messy rollout of this fall’s new COVID ... FDA panel’s recommendation is endorsed by the CDC, only a single composition of vaccine – in this case, the updated bivalent ...
For the study, FDA investigators looked at the medical claims of more than 5.3 million adults ages 65 and older who were enrolled in Medicare and received a bivalent Covid-19 vaccine made by ...
Last fall, U.S. health officials authorized new COVID-19 booster shots designed ... on whether a second bivalent booster dose is needed right now. However, the FDA recently proposed switching ...
Along with allowing a second shot for some adults, the CDC is also working to streamline its COVID ... of the bivalent vaccine or whichever vaccine becomes available in the future. "FDA has ...
Moderna announced Thursday it has submitted an application to the Food and Drug Administration (FDA) for authorization of its updated COVID-19 ... Unlike the bivalent vaccine that was made ...